17-5521756-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033004.4(NLRP1):c.3551T>C(p.Met1184Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0132 in 1,612,142 control chromosomes in the GnomAD database, including 1,721 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_033004.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLRP1 | NM_033004.4 | c.3551T>C | p.Met1184Thr | missense_variant | 13/17 | ENST00000572272.6 | NP_127497.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLRP1 | ENST00000572272.6 | c.3551T>C | p.Met1184Thr | missense_variant | 13/17 | 1 | NM_033004.4 | ENSP00000460475.1 |
Frequencies
GnomAD3 genomes AF: 0.0199 AC: 3034AN: 152190Hom.: 239 Cov.: 32
GnomAD3 exomes AF: 0.0383 AC: 9583AN: 250332Hom.: 1240 AF XY: 0.0296 AC XY: 4005AN XY: 135334
GnomAD4 exome AF: 0.0125 AC: 18213AN: 1459834Hom.: 1481 Cov.: 32 AF XY: 0.0111 AC XY: 8088AN XY: 726184
GnomAD4 genome AF: 0.0200 AC: 3042AN: 152308Hom.: 240 Cov.: 32 AF XY: 0.0223 AC XY: 1664AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 19. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at